In facial filler literature, the word lift is often used to describe a visible change after treatment. When a three-dimensional facial map shows a region moving upward or outward, that change can easily be summarized as a lifting effect.
However, a change at the skin surface, a contour change caused by volume, and repositioning of deeper tissue are not the same finding.
A 2026 critical review in JPRAS Open examined how the term lift is defined and measured in studies of hyaluronic acid, CaHA, poly-L-lactic acid, polycaprolactone, and hybrid fillers. It did not argue that fillers cannot improve appearance. Its central point was narrower: filler-mediated lift still lacks a shared operational definition, measurement standard, and validated threshold for clinical significance.
This Review Was Not About One Filler
This was not a clinical trial of CaHA, nor a ranking of filler products. It examined how multiple soft-tissue filler studies used the word lift and what evidence they offered for it.
Across the literature, the same term may refer to visual support after volume addition, geometric displacement at the skin surface, improved contour continuity, or improvement perceived by participants and assessors. Treating all of these as interchangeable makes direct comparison difficult.
When a paper reports a lifting effect, the first question is not the size of the number. It is what, exactly, was measured.
3D Imaging Measures the Facial Surface First
Three-dimensional imaging records the spatial shape of the external face at different time points. After registration, it can compare volume, distance, or displacement in a defined facial region. That makes it useful for describing contour change beyond a single before-and-after photograph.
However, the review found that all quantitative measurements in the studies it examined reflected change at the cutaneous surface rather than independent tracking of deeper structures. A scan can support the statement that a surface region changed relative to a reference area. It cannot, on its own, establish that retaining ligaments, deep fat compartments, or other deep structures moved in the same way.
| What 3D data can support | What 3D data cannot establish by itself |
|---|---|
| A change in surface contour, volume, or relative displacement in a defined facial region | Independent tracking and repositioning of deeper tissue |
| Surface geometric differences between time points under a defined protocol | That a visible change comes entirely from collagen formation or one tissue mechanism |
| Within-group or between-group differences under a specific registration and measurement approach | That the difference reaches a validated threshold for clinical significance |
This does not diminish the value of 3D imaging. It places it correctly: 3D scans provide useful surface-geometry evidence, not direct imaging of deep-tissue status.
Millimetres Must Be Read Alongside Error
Displacement maps are often reported in millimetres, but a numerical value is not automatically a stable or comparable conclusion. Reference-region selection, participant positioning and expression, registration stability, and regional instrument repeatability can all influence the result.
The review noted that some reported millimetre-scale effects were similar to, and occasionally smaller than, reported measurement standard deviations or the documented accuracy of the imaging modality. The reviewed studies did not report modality accuracy alongside effect size or pre-specify a clinically meaningful threshold.
A statistically significant difference and a change people can meaningfully perceive are therefore not identical. Without a stated measurement error and clinical-significance standard, an upward shift measured in millimetres remains data that must be interpreted in context, not a stand-alone lifting conclusion.
How Should a 3D “Lift” Map Be Read?
From a measurement and evidence perspective, at least five details should be considered together:
- Are the measurement region, reference region, and registration method clearly described?
- Is instrument repeatability or accuracy reported alongside the observed effect?
- Does the figure show the overall data or only a selected local view?
- Are independent, blinded appearance assessments and participant-reported outcomes included?
- Does the study state in advance what magnitude of change would be clinically meaningful?
These questions do not turn clinical research into an instrument exercise. They allow lift to become a reproducible endpoint instead of a word that different studies use for different outcomes.
How Does This Apply to CaHA Temporal 3D Follow-Up?
An earlier article on this site discussed a CaHA study of temporal contour restoration that used 3D scans to record local volume and surface changes. In an exploratory analysis of a small number of participants, the paper described outward and slightly upward local movement. That observation does not establish whole-face lift.
This is precisely where the current methodology discussion is useful. A 3D image can describe a surface result, but it cannot automatically answer what occurred in deeper tissue or extend a local observation into a fixed conclusion about the whole face. For the study design and follow-up conditions, see How Long Can CaHA Temporal Contour Improvement Last?.
Clinical Results Must Remain at Their Evidence Level
From a materials and evidence-assessment perspective, different levels of data should remain distinct. A 3D scan records a surface result under a specific finished-product system, use condition, and study design. It cannot be used to infer that a particular CaHA powder, microsphere morphology, or raw-material parameter independently produced clinical lift.
Visible improvement may reflect volume, light and shadow, surface tension, and later tissue responses. Only when the measurement method, assessor findings, participant experience, and mechanism evidence support one another does lift have a clearer interpretive boundary.
This article is a public literature review. It discusses the evidence boundary between three-dimensional surface measurement and the concept of lift in soft-tissue filler research. It does not provide medical-product recommendations, clinical indications, or treatment advice.
References
- Harris S, Michon A. Defining and Measuring ‘Lift’ in Soft Tissue Filler-Based Facial Rejuvenation: A Critical Review and Proposed Framework. JPRAS Open. 2026;51:646–656. DOI: 10.1016/j.jpra.2026.07.028.
- Zhu D, Chen J, Wei W, et al. Clinical and Three-Dimensional Evaluation of Calcium Hydroxylapatite for Temporal Contour Restoration in a Chinese Population. Journal of Cosmetic Dermatology. 2026;25(7):e71026. DOI: 10.1111/jocd.71026.